These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 22065842)
1. Regulating complement in the kidney: insights from CFHR5 nephropathy. Gale DP; Pickering MC Dis Model Mech; 2011 Nov; 4(6):721-6. PubMed ID: 22065842 [TBL] [Abstract][Full Text] [Related]
2. Complement and glomerular disease: new insights. Pickering M; Cook HT Curr Opin Nephrol Hypertens; 2011 May; 20(3):271-7. PubMed ID: 21422921 [TBL] [Abstract][Full Text] [Related]
3. Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy. Frangou E; Varnavidou-Nicolaidou A; Petousis P; Soloukides A; Theophanous E; Savva I; Michael N; Toumasi E; Georgiou D; Stylianou G; Mean R; Anastasiadou N; Athanasiou Y; Zavros M; Kyriacou K; Deltas C; Hadjianastassiou V Nephrol Dial Transplant; 2019 Oct; 34(10):1780-1788. PubMed ID: 30844074 [TBL] [Abstract][Full Text] [Related]
4. Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant. Vernon KA; Gale DP; de Jorge EG; McLean AG; Galliford J; Pierides A; Maxwell PH; Taube D; Pickering MC; Cook HT Am J Transplant; 2011 Jan; 11(1):152-5. PubMed ID: 21114651 [TBL] [Abstract][Full Text] [Related]
5. C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families. Deltas C; Gale D; Cook T; Voskarides K; Athanasiou Y; Pierides A Adv Exp Med Biol; 2013; 735():189-96. PubMed ID: 23402027 [TBL] [Abstract][Full Text] [Related]
6. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Gale DP; de Jorge EG; Cook HT; Martinez-Barricarte R; Hadjisavvas A; McLean AG; Pusey CD; Pierides A; Kyriacou K; Athanasiou Y; Voskarides K; Deltas C; Palmer A; Frémeaux-Bacchi V; de Cordoba SR; Maxwell PH; Pickering MC Lancet; 2010 Sep; 376(9743):794-801. PubMed ID: 20800271 [TBL] [Abstract][Full Text] [Related]
7. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Athanasiou Y; Voskarides K; Gale DP; Damianou L; Patsias C; Zavros M; Maxwell PH; Cook HT; Demosthenous P; Hadjisavvas A; Kyriacou K; Zouvani I; Pierides A; Deltas C Clin J Am Soc Nephrol; 2011 Jun; 6(6):1436-46. PubMed ID: 21566112 [TBL] [Abstract][Full Text] [Related]
8. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry. Medjeral-Thomas N; Malik TH; Patel MP; Toth T; Cook HT; Tomson C; Pickering MC Kidney Int; 2014 Apr; 85(4):933-7. PubMed ID: 24067434 [TBL] [Abstract][Full Text] [Related]
14. Clinical research advances of CFHR5 nephropathy: a recent review. Fei ZG; Zhen K; Zhang FJ; Liu PY; Xu HY; Chen HH Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9987-10000. PubMed ID: 37916369 [TBL] [Abstract][Full Text] [Related]
15. Recurrence of dense deposits in transplanted kidney: II. Serum complement and nephritic factor profiles. Leibowitch J; Halbwachs L; Wattel S; Gaillard MH; Droz D Kidney Int; 1979 Apr; 15(4):396-403. PubMed ID: 390216 [TBL] [Abstract][Full Text] [Related]
16. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy. Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035 [TBL] [Abstract][Full Text] [Related]
17. FHR-5 Serum Levels and Garam N; Cserhalmi M; Prohászka Z; Szilágyi Á; Veszeli N; Szabó E; Uzonyi B; Iliás A; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Rysava R; Reiterova J; Saraga M; Seeman T; Zieg J; Sládková E; Stajic N; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Józsi M; Csuka D Front Immunol; 2021; 12():720183. PubMed ID: 34566977 [TBL] [Abstract][Full Text] [Related]
18. Complement factor H-related hybrid protein deregulates complement in dense deposit disease. Chen Q; Wiesener M; Eberhardt HU; Hartmann A; Uzonyi B; Kirschfink M; Amann K; Buettner M; Goodship T; Hugo C; Skerka C; Zipfel PF J Clin Invest; 2014 Jan; 124(1):145-55. PubMed ID: 24334459 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against alternative complement pathway proteins in renal pathologies. Nozal P; López-Trascasa M Nefrologia; 2016; 36(5):489-495. PubMed ID: 27267919 [TBL] [Abstract][Full Text] [Related]
20. Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy. Zhai YL; Meng SJ; Zhu L; Shi SF; Wang SX; Liu LJ; Lv JC; Yu F; Zhao MH; Zhang H J Am Soc Nephrol; 2016 Sep; 27(9):2894-905. PubMed ID: 26825529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]